1 |
Grogan TM, Lippman SM, Spier CM, et al. Independent prognostic significance of a nuclear proliferation antigen in diffuse large cell lymphomas as determined by the monoclonalantibody Ki-67. Blood 1988;71:1157-1160
PUBMED
|
2 |
Leoncini L, Vecchio MTD, Spina D, et al. Presence of the bcl-2 protein and apoptosis in non-Hodgkin lymphomas with diffuse growth pattern. Int J Cancer 1995:61:826-831
|
3 |
Du M, Singh N, Husseuin A, Isaacson PG and Pan L. Positive correlation between apoptotic and proliferative indices in gastrointestinal lymphomas of mucosa-associated lymphoidtissue (MALT). J Pathol 1996;178:379-384
DOI
PUBMED
|
4 |
Kalogeraki A, Tzardi M, Panagiotides I, et al. MIB1 (Ki67) expression in non-Hodgkin's lymphomas. Anticancer Res 1997;17:487-492
DOI
PUBMED
ScienceOn
|
5 |
Han JH, Yang WI, Kim TS. Prognostic implications of Ki67 labelling index and p53, bcl-2 protein expression in the primary central nervous system lymphoma. Korean J Pathol 2000;34:456-464
|
6 |
Kramer MHH, Hermans J, Parker ADG, et al. Clinicalsignificance of bcl2 and p53 protein expression in diffuselarge B-cell lymphoma : a population-based study. J Clin Oncol 1996;14:2131-2138
DOI
|
7 |
Komaki R, Fujii T, Perkins P, et al. Apoptosis and mitosis as prognostic factors in pathologically staged N1 nonsmall cell lung cancer. Int J Radiat Oncol Biol Phys 1996;36:601-605
DOI
PUBMED
ScienceOn
|
8 |
Czader M, Mazur J, Pettersson M, et al. Prognostic significance of proliferative and apoptotic fractions in low gradefollicle center cell-derived non-Hodgkin's lymphomas. Cancer 1996;77:1180-1188
DOI
ScienceOn
|
9 |
Cotter TG, Lennon SV, Glynn JG, Martin SJ . Cell deathvia apoptosis and its relationship to growth. Development and differentiation of both tumours and normal cells. Anticancer Res 1990;10:1153-1160
PUBMED
|
10 |
Levine EL, Davidson SE, Roberts SA, Chadwick CA, Potten CS, West CML. Apoptosis as predictor of response to radiotherapy in cervical carcinoma. Lancet 1994; 344:472
|
11 |
Slymen D, Miller TP, Lippman SM, et al. Immunobiologicfactors predictive of clinical outcome in diffuse large- cell lymphoma. J Clin Oncol 1990;8:986-993
DOI
PUBMED
|
12 |
Ko YH, Kim CW, Park CS, et al. REAL classification of malignant lymphomas in the Republic of Korea. Cancer 1998;83:806-812
DOI
ScienceOn
|
13 |
Hill ME, MacLennan KA, Cunningham DC, et al. Prognostic significance of Bcl-2 expression and bcl-2 majorbreakpoint region rearrangement in diffuse large cell nonHodgkin's lymphoma: a British National Lymphoma Investigation Study. Blood 1996;88:1046-1051
PUBMED
|
14 |
Wheaton S, Netser J, Guinee D, Rahn M and Perkins S. BcI-2 and Bax protein expression in indolent versusaggressive B-cell non-Hodgkin's lymphomas. Human Pathol 1998;29:820-825
DOI
ScienceOn
|
15 |
Gascoyne RD, Adomat SA, Krajewski S, et al. Prognostic significance of BcI-2 protein expression and bcl-2 generearrangement in diffuse aggressive non-Hodgkin's lymphoma. Blood 1997;90:244-251
PUBMED
|
16 |
Wyllie AH. Apoptosis Br J Cancer 1993;67:205-208
|
17 |
Koduru PRK, Raju K, Vadmal V, et al. Correlationbetween mutation in P53, p53 expression, cytogentics, histologic type, and survival in patients with B-cell non-Hodgkin's lymphoma. Blood 1997;90:4078-4091
|
18 |
Logsdon MD, Meyn RE, Besa PC, et al. Apoptosis and the bcl-2 gene family - patterns of expression and prognostic value in stage I and II follicular center lymphoma. Int J Radiat Oncol Biol Phys 1999;44:19-29
DOI
PUBMED
ScienceOn
|
19 |
Takano Y, Saegusa M, Ikenaga M, and Okayasu I. Apoptosis and proliferative activity of non-Hodgkin's lymphomas : comparison with expression of bcl-2, p53 and c-mycproteins. Pathol International 1997:47:90-94
|
20 |
Reed JC. BcI-2 and the regulation of programmed cell death. J Cell Biol 1994;124:1-6
DOI
ScienceOn
|
21 |
Piris MA. Pezella F, Martinez-z Montero JC, Orradre JL, et al. P53- and bcl-2 expression in high-grade B-cell lymphomas : correlation with survival time. Br J Cancer 1994;69:337-341
DOI
|
22 |
Korkolopoulou P, Angelopoulou MK, Kontopidou F, et al. Prognostic relevance of apoptotic cell death in non-Hodgkin's lymphomas: a multivariate survival analysis including Ki-67 and p53 oncoprotein expression. Histopathology 1998:33:240-247
|
23 |
Chung EJ, Seong J, Yang WI, et al. Spontaneous apoptosis as a predictor of radiotherapy in patients with stage llB squamous cell carcinoma of the uterine cervix. Acta Oncol 1999;38:449-454
DOI
ScienceOn
|
24 |
Miller TP, Grogan TM, Dahlberg S, et al. Prognostic significance of the Ki-67- associated proliferative antigen in aggressive non-Hodgkin's lymphomas: a prospective southwest oncology group trial. Blood 1994:83:1460-1466
|
25 |
Hall PA, Richards MA, Gregory WM, d'Ardenne AJ, Lister TA, and Stansfeld AG. The prognostic value of Ki67 immunostaining in non-Hodgkin's lymphoma. J Pathol 1998;154:223-235
DOI
|
26 |
Wheeler JS, Stephens L, Eifel P, et al. Apoptosis as a predictor of tumor response to radiation in stage IB cervicaladenocarcinoma. Int J Radiat Oncol Biol Phys 1995;32:1487-1493
DOI
ScienceOn
|
27 |
Leoncini L, Vecchio MTD, Megha T, et al. Correlations between apcototc and proliferative indices in malignant nonHodgkin's lymphomas. Am J Pathol 1993:142:755-763
|
28 |
Park SS, Huh JR, Lee SS, Kang YK, Heo DS, and Kim CW. Correlation between clinical outcome and proliferationindex in diffuse large B-Cell lymphoma. Korean J Pathol 1999;33:475-482
|
29 |
Offit K, Coco FL, Louie DC, et al. Rearrangement of the bcl-6 gene as a prognostic marker in diffuse large-cell lymphoma. N Engl J Med 1994;331:74-80
DOI
ScienceOn
|
30 |
Gisbertz lAM, Schouten HC, Bot FJ, Arends JW. Cellturnover parameters in small and large cell varieties of primary intestinal non-Hodgkin's lymphoma. Cancer 1998;83:158-165
DOI
ScienceOn
|
31 |
Lera J, Lara PC, Perez S, Cabrera JL, Santana C. Tumor proliferation, p53 expression, and apoptosis in laryngealcarcinoma: relation to the results of radiotherapy. Cancer 1998;83:2493-2501
DOI
ScienceOn
|
32 |
Aihara M, Scardino PT, Truong LD, et al. The frequencyelates with the prognosis of Gleason grade 3 adenocarcinoma of the prostate. Cancer 1995;75:522-529
DOI
ScienceOn
|
33 |
Soini Y, Raunio H, Paakko P. High-grade malignant nonHodgkin's lymphomas differ from low-grade lymphomas in the extent of apoptosis and their expression of bcl-2, mcl-1, bax and p53. Tumor Biol 1998;19:176-185
DOI
ScienceOn
|
34 |
Lee MJ, Jeon HJ, Chung CD, Park YH, Kim M. REAL classification and expression of Cyclin D1, BcI-2 , p53 and BcI- 6 protein in non-Hodgkin's lymphoma. Med J Chosun Univ 2001;26:32-39
|
35 |
Hermine O, Haioun C, Lepage E, et al. Prognostic significance of bcl-2 protein expression in aggressive nonHodgkin's lymphoma. Blood 1996;87:265-272
PUBMED
|